Cible Skin has received a minority investment from Verlinvest, which will help to accelerate growth across geographies including Europe, China and the United States, and support the development of new products and treatments based on the company’s innovative patented immuno-cosmetic approach.
Cible Skin takes a research-backed approach to developing high-quality formulations, made in France with natural, clean, active ingredients, and offers skin care products including cleansers, serums and moisturizers.
The brand also offers a range of exclusive treatments at its flagship clinic in Paris, La Maison Cible Skin, providing customers with both a luxurious experience and personalized, technical and scientific guidance through their skin care journey.
Raphael Thiolon, managing director at Verlinvest said, “It is rare in the beauty industry to find a brand like Cible Skin which combines a truly innovative product offering with a science-backed mission and phenomenal results that customers love. Verlinvest is thrilled to be partnering with Raphaël, Jean, and their team to bring Cible Skin’s unique immuno-cosmetic approach to the most discerning skin care consumers around the world.”
Cecile Chevallier, principal at Verlinvest added, “We’re excited to support Cible Skin’s expansion in existing and new markets, and our immediate priority will be to help the business in growing digital, commercial and marketing capabilities, as well as reinforcing its brand, community and organization.”
Jean Ginefri, president and co-founder of Cible Skin said, “With this investment from Verlinvest, Cible Skin will be able to accelerate deployment in our two main markets, France and China, while evaluating potential for further expansion across Europe and America. Cible Skin stands out in the competitive skincare industry through the unrivalled satisfaction and advocacy from our customers. Our goal over the next five years is to become the market leader in luxury, science-backed, cosmetics and we believe Verlinvest is the perfect partner to help us on this path, with their track record of supporting strong international growth while preserving and strengthening the DNA of the brands they back.”
Raphaël Aknin, Ph.D., CEO and co-founder at Cible Skin added, “From the start of this partnership, we have been aligned with Raphael and Cécile on the fundamental role that science, research, and product development plays at Cible Skin. Their support will allow us to achieve our ambition of establishing Cible Skin as a global leader in scientific innovation to better serve the health and beauty of all skin types through best-in-class product efficacy.”
